SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Operating Income

-$304.36M

TTM · Period ending: · USD

DMRA logo

DMRA Operating Income

Latest reported-$304.36M
DMRA Operating Income (-$12.91M → -$304.36M)
Powered by
High-resolution chart · PNG

What is operating income?

Operating income is profit from the core business after operating costs, before interest and income taxes.

Compare operating income

DMRA operating income history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Operating Income — Annual fiscal periods (USD)
Period endingOperating Income (USD)Change
-210,872,000—
-16,897,000—
-36,457,000—
-61,207,000—
-52,227,000—
-33,637,000—
-38,971,000—
-12,907,000—

Frequently asked questions: DMRA operating income

What is Damora Therapeutics, Inc. (DMRA)'s current operating income?

Damora Therapeutics, Inc. (DMRA)'s latest reported operating income (TTM) is -$304.36M as of Sep 30, 2026. Operating income is profit from the core business after operating costs, before interest and income taxes.

How much historical operating income data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s operating income, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's operating income to peers or set an alert?

You can compare DMRA's operating income directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.